These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 21461582

  • 1. Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk.
    Ziva Cerne J, Stegel V, Gersak K, Novakovic S.
    Mol Med Rep; 2011; 4(1):175-9. PubMed ID: 21461582
    [Abstract] [Full Text] [Related]

  • 2. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study.
    Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN, Henderson BE.
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2071-7. PubMed ID: 15598763
    [Abstract] [Full Text] [Related]

  • 3. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
    Ericson U, Sonestedt E, Ivarsson MI, Gullberg B, Carlson J, Olsson H, Wirfält E.
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
    [Abstract] [Full Text] [Related]

  • 4. Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer.
    Cerne JZ, Novakovic S, Frkovic-Grazio S, Pohar-Perme M, Stegel V, Gersak K.
    Oncol Rep; 2011 Aug; 26(2):479-85. PubMed ID: 21567099
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
    Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, Yamashita T, Iwata H, Tajima K.
    Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of the contribution of methylenetetrahydrofolate reductase genotypes to Taiwan breast cancer.
    Huang CY, Chang WS, Shui HA, Hsieh YH, Loh CH, Wang HC, Ji HX, Hsiao CL, Hsu CM, Tsai CW, Bau DT.
    Anticancer Res; 2014 Aug; 34(8):4109-15. PubMed ID: 25075036
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
    Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J.
    Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
    [Abstract] [Full Text] [Related]

  • 16. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer.
    Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, Teitelbaum SL, Britton JA, Terry MB, Neugut AI, Santella RM.
    Cancer Res; 2005 Feb 15; 65(4):1606-14. PubMed ID: 15735051
    [Abstract] [Full Text] [Related]

  • 17. [MTHFR polymorphisms, dietary folate intake and risks to breast cancer].
    Gao CM, Kazuo T, Tang JH, Cao HX, Ding JH, Wu JZ, Wang J, Liu YT, Li SP, Su P, Keitaro M, Toshiro T.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jul 15; 43(7):576-80. PubMed ID: 19954067
    [Abstract] [Full Text] [Related]

  • 18. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
    Reljic A, Simundic AM, Topic E, Nikolac N, Justinic D, Stefanovic M.
    Clin Biochem; 2007 Sep 15; 40(13-14):981-5. PubMed ID: 17573062
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.